Biorelate
PrivateLast Round
Series A
Nov 29, 2022
Total Funding Raised
$8.98M
Momentum Score
25 /100
Company Overview
Biorelate is a UK-based technology company that has developed Galactic AI™, an artificial intelligence platform for biomedical data curation. The platform utilizes natural language processing (NLP) and machine learning to analyze vast amounts of unstructured biomedical data from published literature and other text sources. It extracts and organizes causal relationships between biological entities like genes, drugs, and diseases to create a comprehensive knowledge graph. This service enables pharmaceutical and life sciences organizations to accelerate their research and development processes, including target discovery, biomarker identification, and understanding mechanisms of action. Founded in 2014 as a spinout from the University of Manchester, the company is privately held and has received venture capital funding from investors including YFM Equity Partners and Maven Capital Partners.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Medical AI, Biotechnology, NLP & Conversational AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting, Government Contracts, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biorelate Comps
Public and private peers based on sector, stage, and business model.
Biorelate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 29, 2022 | ||||
| Grant | Feb 18, 2019 | ||||
| Seed | Sep 18, 2018 |
Biorelate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NPIF - Maven Equity Finance | Seed, Series A |
| Innovate UK | Grant |
| Triple Point Ventures | Series A |
| The GM&C Life Sciences Fund | Seed |
| YFM Equity Partners | Series A |
| Catapult Ventures | Seed |
| Maven Capital Partners | Series A |
Biorelate Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biorelate's valuation, stock price, and market status.
